Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2389)

PROPOSED CHANGE OF COMPANY NAME

The Board proposes to change the English name of the Company from "Beijing Enterprises Medical and Health Industry Group Limited" to "Beijing Health (Holdings) Limited" and the Chinese name of the Company from "̏છᔼᐕ਄ੰପุණྠϞࠢʮ̡"

to" ̏ԯ਄ੰ€છٰϞࠢʮ̡".

The Proposed Change of Company Name is subject to (i) the passing of a special resolution by the Shareholders at the forthcoming AGM approving the Proposed Change of Company Name; and (ii) the Registrar of Companies in the Cayman Islands approving the Proposed Change of Company Name by issuing a certificate of incorporation on change of name.

A circular containing, among other matters, information in relation to the Proposed Change of Company Name and a notice convening the AGM will be despatched to the Shareholders as soon as practicable.

PROPOSED CHANGE OF COMPANY NAME

The board (the "Board") of directors (the "Director(s)") of Beijing Enterprises Medical and Health Industry Group Limited (the "Company", together with its subsidiaries, the "Group") proposes to change the English name of the Company from "Beijing Enterprises Medical and Health Industry Group Limited" to "Beijing Health (Holdings) Limited" and to change the Chinese name of the Company from "̏છᔼᐕ਄ੰପุණྠϞࠢʮ̡ "to" ̏ԯ ਄ੰ€છٰϞࠢʮ̡" (the "Proposed Change of Company Name").

Conditions of the Proposed Change of Company Name

The Proposed Change of Company Name is subject to the following conditions:

  • (1) the passing of a special resolution by the shareholders of the Company (the "Shareholders") to approve the Proposed Change of Company Name at the forthcoming annual general meeting of the Company (the "AGM"); and

  • (2) the Registrar of Companies in the Cayman Islands approving the Proposed Change of Company Name by issuing a certificate of incorporation on change of name.

The relevant filings of the Registrar of Companies in the Cayman Islands will be made after the passing of the special resolution at the forthcoming AGM to be held by the Company. Subject to the satisfaction of the conditions set out above, the Proposed Change of Company Name will take effect from the date of entry of the new name of the Company on the register maintained by the Registrar of Companies in the Cayman Islands. The Company will then carry out the necessary filing procedures with the Companies Registry in Hong Kong.

In addition, subject to the confirmation of The Stock Exchange of Hong Kong Limited (the "Stock Exchange"), the English and Chinese stock short names for trading in the shares of the Company (the "Shares") will also be changed after the Proposed Change of Company Name becomes effective.

REASONS FOR THE PROPOSED CHANGE OF COMPANY NAME

The Company is an investment holding company and the Group is principally engaged in provision of medical care, health care and geriatric care related services and products.

The Board evaluates from time to time the business strategies of the Group. It is not only dedicated to develop the Group's existing core businesses but is also dynamic in value creation through diversification and expansion into new business area. The Board considers that the Proposed Change of Company Name will reflect more accurately the nature of business of the Group and the business focus and strategy of the Group in the future. The Board believes the new name can provide the Company with a more defined corporate image and identity which will benefit the Company's business development and is in the interests of the Company and the Shareholders as a whole.

EFFECT OF THE PROPOSED CHANGE OF COMPANY NAME

The Proposed Change of Company Name will not affect the rights of any Shareholder. All existing share certificates of the Company in issue bearing the present name of the Company will, upon the Proposed Change of Company Name becoming effective, continue to be effective and as valid evidence of legal title to the Shares and will continue to be valid for trading, settlement, registration and delivery purposes.

Accordingly, there will not be any arrangement for the free exchange of existing share certificates for new share certificates bearing the new name of the Company. Should the Proposed Change of Company Name become effective, any further issue of share certificates thereafter will bear the new name of the company and the securities of the Company will be traded on the Stock Exchange under the new name.

GENERAL

The Proposed Change of Company Name is subject to Shareholders' approval at the forthcoming AGM and no Shareholders are required to abstain from voting on the resolution in relation to the Proposed Change of Company Name. A circular containing, among other things, details regarding the Proposed Change of Company Name and the notices convening the forthcoming AGM will be despatched to the Shareholders as soon as practicable. Further announcement(s) will be made by the Company as and when appropriate to inform the Shareholders of, among other things, the effective date of the Proposed Change of Company Name and, where necessary, the change of stock short names of the Company for trading of the Shares on the Stock Exchange.

By order of the Board

Beijing Enterprises Medical and Health

Industry Group Limited

Zhu Shi Xing

Chairman

Hong Kong, 15 March 2021

As at the date of this announcement, the Board comprises seven executive Directors, namely Mr. Zhu Shi Xing, Mr. Liu Xue Heng, Mr. Gu Shan Chao, Mr. Siu Kin Wai, Mr. Hu Shiang Chi, Mr. Wang Zheng Chun and Mr. Zhang Jing Ming and five independent non-executive Directors, namely Mr. Robert Winslow Koepp, Mr. Gary Zhao, Mr. Tse Man Kit, Keith, Mr. Wu Yong Xin and Mr. Zhang Yun Zhou.

Attachments

  • Original document
  • Permalink

Disclaimer

Beijing Enterprises Medical and Health Industry Group Limited published this content on 15 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 March 2021 11:52:01 UTC.